In ob/ob mice, liver-specific silencing of ChREBP can prevent hepatic steatosis and improve peripheral insulin sensitivity, and its mechanism involves the reduction of hepatic DNL (50, 53). This evidence concerns the gene MLXIPL and Hepatic steatosis.